References
- Bae, S. J., J. H. Oum, S. Sharma, J. Park, and S. W. Lee. 2002. In vitro selection of specific RNA inhibitors of NFATc. Biochem. Biophys. Res. Commun. 298: 486-492 https://doi.org/10.1016/S0006-291X(02)02490-7
- Burgstaller, P., A. Girod, and M. Blind. 2002. Aptamers as tools for target prioritization and lead identification. Drug Discov. Today 7: 1221-1228 https://doi.org/10.1016/S1359-6446(02)02522-9
- Daniels, D. A., H. Chen, B. J. Ricke, K. M. Swiderek, and L. Gold. 2003. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proc. Natl. Acad. Sci. USA 100: 15416-15421
- Ellington, A. D. and J. W. Szostak. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822 https://doi.org/10.1038/346818a0
- Gold, L., P. Allen, J. Binkley, D. Brown, D. Schneider, S. R. Eddy, C. Tuerk, L. Green, S. Macdougal, and D. Tasset. 1993. RNA: The shape of things to come, pp. 497-510. In R. F. Gestelend and J. F. Atkins (eds.). The RNA World. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., U.S.A
- Hwang, B., K. Han, and S. W. Lee. 2003. Prevention of passively transferred experimental autoimmune myasthenia gravis by an in vitro selected RNA aptamer. FEBS Lett. 548: 85-89 https://doi.org/10.1016/S0014-5793(03)00745-2
- Hwang, B. and S. W. Lee. 2005. Analysis of in vivo interaction of HCV NS3 protein and specific RNA aptamer with yeast three-hybrid system. J. Microbiol. Biotechnol. 15: 660-664
- Jung, H. S. and S. W. Lee. 2005. Re-engineering of carcinoembryonic antigen RNA with the group I intron of Tetrahymena thermophila by targeted trans-splicing. J. Microbiol. Biotechnol. 15: 1408-1413
- Kim, H., S. J. Kim, S. N. Park, and J. W. Oh. 2004. Antiviral effect of amphotericin B on Japanese encephalitis virus replication. J. Microbiol. Biotechnol. 14: 121-127
- Klubmann, S., A. Nolte, A. Bald, V. A. Erdmann, and J. P. Furste. 1996. Mirror-image RNA that binds D-adenosine. Nat. Biotechnol.14: 1112-1115 https://doi.org/10.1038/nbt0996-1112
- Lauhon, C. T. and J. W. Szostak. 1995. RNA aptamers that bind flavin and nicotinamide redox cofactors. J. Am. Chem. Soc. 117: 1246-1257 https://doi.org/10.1021/ja00109a008
- Lee, S. W. and B. Sullenger. 1996. Isolation of a nuclease resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes. J. Exp. Med.194: 315-324
- Lee, S. W. and B. Sullenger. 1997. Isolation of a nucleaseresistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies. Nat. Biotechnol. 15: 41-45 https://doi.org/10.1038/nbt0197-41
- Lim, H., M. K. Kim, Y. H. Cho, J. M. Kim, Y. Lim, and C. H. Lee. 2004. Inhibition of cell cycle progression and induction of apoptosis in HeLa cells by HY558-1, novel CDK inhibitor isolated from Penicillium minioluteum F558. J. Microbiol. Biotechnol. 14: 978-984
- Lupold, S. E., B. Hicke, Y. Lin, and D. S. Coffey. 2002. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 62: 4029-4033
- Morris, K. N., K. B. Jensen, C. M. Julin, M. Well, and L. Gold. 1998. High affinity ligands from in vitro selection: Complex targets. Proc. Natl. Acad. Sci. USA 95: 2902-2907
- Pagratis, N. C., C. Bell, Y. F. Chang, S. Jennings, T. Fitzwater, D. Jellinek, and C. Dang. 1997. Potent 2'-amino, and 2'-fluoro-2'deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nature Biotechnol. 15: 68-73 https://doi.org/10.1038/nbt0197-68
- Park, K. S., Y. J. Bae, E. J. Jung, and S. J. Kang. 2005. RTPCR-based detection of six garlic viruses and their phylogenetic relationships. J. Microbiol. Biotechnol. 15: 1110-1114
- Rosemeyer, V., A. Laubrock, and R. Seibl. 1995. Nonradioactive 3'-end-Iabeling of RNA molecules of different lengths by terminal deoxynucleotidyltransferase. Anal. Biochem. 224: 446-449 https://doi.org/10.1006/abio.1995.1068
- Rusconi, C. P., J. D. Roberts, G. A. Pitoc, S. M. Nimjee, R. R. White, G. Jr. Quick, E. Scardino, W. P. Fay, and B. A. Sullenger. 2004. Antidote-mediated control of an anticoagulant aptamer in vivo. Nat. Biotechnol. 22: 1423-1428 https://doi.org/10.1038/nbt1023
- Seo, H. S. and S. W. Lee. 2000. In vitro selection of the 2'-fluoro-2'-deoxyribonucleotide decoy RNA inhibitor of myasthenic autoantibodies. J. Microbiol. Biotechnol. 10: 707-713
- Strausberg, R. L., A. J. Simpson, L. J. Old, and G. J. Riggins. 2004. Oncogenomics and the development of new cancer therapies. Nature 429: 469-474 https://doi.org/10.1038/nature02627
- Sullenger, B. A. and E. Gilboa. 2002. Emerging clinical applications of RNA. Nature 418: 252-258 https://doi.org/10.1038/418252a
- Tuerk, C. and L. Gold. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510 https://doi.org/10.1126/science.2200121
- Wang, C., M. Zhang, G. Yang, D. Zhang, H. Ding, H. Wang, M. Fan, B. Shen, and N. Shap. 2003. Single-stranded DNA aptamers that bind differentiated but not parental cells: Subtractive systemic evolution of ligands by exponential enrichment. J. Biotechnol. 102: 15-22 https://doi.org/10.1016/S0168-1656(02)00360-7